مراجعة
Diabetes half-way between type 1 and type 2. LADA - the second biggest diabetic group where best treatment is uncertain / Diabetes mitt emellan typ 1 och 2. LADA - näst största diabetesgruppen där bästa behandling är osäker
العنوان: | Diabetes half-way between type 1 and type 2. LADA - the second biggest diabetic group where best treatment is uncertain / Diabetes mitt emellan typ 1 och 2. LADA - näst största diabetesgruppen där bästa behandling är osäker |
---|---|
المؤلفون: | Björklund, A, Grill, V, Carlsson, S, Groop, L |
المصدر: | Läkartidningen. 105(21):1568 |
قاعدة البيانات: | SveMed+ |
ResultId |
1 |
---|---|
Header |
edssmd SveMed+ edssmd.105998 759 2 Review review 758.664306640625 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edssmd&AN=edssmd.105998&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://svemedplus.kib.ki.se/Default.aspx?Dok_ID=105998 [Name] => EDS - SveMed+ [Category] => fullText [Text] => View record in SveMed+ [MouseOverText] => View record in SveMed+ ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edssmd&genre=article&issn=00237205&ISBN=&volume=105&issue=21&date=20080101&spage=1568&pages=&title=Läkartidningen&atitle=Diabetes%20half-way%20between%20type%201%20and%20type%202.%20LADA%20-%20the%20second%20biggest%20diabetic%20group%20where%20best%20treatment%20is%20uncertain%20%2F%20Diabetes%20mitt%20emellan%20typ%201%20och%202.%20LADA%20-%20n%C3%A4st%20st%C3%B6rsta%20diabetesgruppen%20d%C3%A4r%20b%C3%A4sta%20behandling%20%C3%A4r%20os%C3%A4ker&id=DOI: [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Diabetes half-way between type 1 and type 2. LADA - the second biggest diabetic group where best treatment is uncertain / Diabetes mitt emellan typ 1 och 2. LADA - näst största diabetesgruppen där bästa behandling är osäker
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Björklund%2C+A%22">Björklund, A</searchLink><br /><searchLink fieldCode="AR" term="%22Grill%2C+V%22">Grill, V</searchLink><br /><searchLink fieldCode="AR" term="%22Carlsson%2C+S%22">Carlsson, S</searchLink><br /><searchLink fieldCode="AR" term="%22Groop%2C+L%22">Groop, L</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Läkartidningen</i>. 105(21):1568 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Swedish
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[StartPage] => 1568
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Diabetes half-way between type 1 and type 2. LADA - the second biggest diabetic group where best treatment is uncertain / Diabetes mitt emellan typ 1 och 2. LADA - näst största diabetesgruppen där bästa behandling är osäker
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Björklund, A
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Grill, V
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Carlsson, S
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Groop, L
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2008
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 00237205
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 105
)
[1] => Array
(
[Type] => issue
[Value] => 21
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Läkartidningen
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |